R
Revital Nimri
Researcher at San Antonio River Authority
Publications - 46
Citations - 4885
Revital Nimri is an academic researcher from San Antonio River Authority. The author has contributed to research in topics: Diabetes mellitus & Type 1 diabetes. The author has an hindex of 23, co-authored 38 publications receiving 3323 citations. Previous affiliations of Revital Nimri include Children's Medical Center of Dallas.
Papers
More filters
Journal ArticleDOI
Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range
Tadej Battelino,Thomas Danne,Richard M. Bergenstal,Stephanie A. Amiel,Roy W. Beck,Torben Biester,Emanuele Bosi,Bruce A. Buckingham,William T. Cefalu,Kelly L. Close,Claudio Cobelli,Eyal Dassau,J. Hans DeVries,Kim C. Donaghue,Klemen Dovc,Francis J. Doyle,Satish K. Garg,George Grunberger,Simon Heller,Lutz Heinemann,Irl B. Hirsch,Roman Hovorka,Weiping Jia,Olga Kordonouri,Boris Kovatchev,Aaron J. Kowalski,Lori M. Laffel,Brian J. Levine,Alexander Mayorov,Chantal Mathieu,Helen R. Murphy,Revital Nimri,Kirsten Nørgaard,Christopher G. Parkin,Eric Renard,David Rodbard,Banshi Saboo,Desmond A. Schatz,Keaton C. Stoner,Tatsuiko Urakami,Stuart A. Weinzimer,Moshe Phillip,Moshe Phillip +42 more
TL;DR: This article summarizes the ATTD consensus recommendations for relevant aspects of CGM data utilization and reporting among the various diabetes populations.
Journal ArticleDOI
Effect of Continuous Glucose Monitoring on Hypoglycemia in Type 1 Diabetes
TL;DR: Continuous glucose monitoring was associated with reduced time spent in hypoglycemia and a concomitant decrease in HbA1c in children and adults with type 1 diabetes.
Journal ArticleDOI
Nocturnal Glucose Control with an Artificial Pancreas at a Diabetes Camp
Moshe Phillip,Tadej Battelino,Eran Atlas,Olga Kordonouri,Natasa Bratina,Shahar Miller,Torben Biester,Magdalena Avbelj Stefanija,Ido Muller,Revital Nimri,Thomas Danne +10 more
TL;DR: Patients at a diabetes camp who were treated with an artificial-pancreas system had less nocturnal hypoglycemia and tighter glucose control than when they were treating with a sensor-augmented insulin pump.
Journal ArticleDOI
MD-Logic Artificial Pancreas System: A pilot study in adults with type 1 diabetes
TL;DR: The MDLAP system is a promising tool for individualized glucose control in patients with type 1 diabetes and is designed to minimize high glucose peaks while preventing hypoglycemia.
Journal ArticleDOI
Glibenclamide Treatment in Permanent Neonatal Diabetes Mellitus due to an Activating Mutation in Kir6.2
TL;DR: The feasibility of oral sulfonylurea treatment in PNDM patients with Kir6.2 mutations even during infancy is demonstrated, and the superiority of this approach over insulin administration is demonstrated.